T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis
Daria Briukhovetska, Javier Suárez-Gosálvez, Cornelia Voigt, Anamarija Markota, Anastasios D. Giannou, Maryam Schübel, Jakob Jobst, Tao Zhang, Janina Dörr, Florian Märkl, Lina Majed, Philipp Jie Müller, Peter May, Adrian Gottschlich, Nicholas Tokarew, Jöran Lücke, Arman Öner, Melanie Schwerdtfeger, David Andreu-Sanz, Ruth Grünmeier, Matthias Seifert, Stefanos Michaelides, Michael Hristov, Lars M. König, Bruno L. Cadilha, Oleg Mikhaylov, Hans‐Joachim Anders, Simon Rothenfußer, Richard A. Flavell, Daniela Cerezo‐Wallis, Cristina Tejedo, Marı́a S. Soengas, Tobias Bald, Samuel Huber, Stefan Endres, Sebastian Kobold
Topics & Concepts
BiologyCancer researchMetastasisImmunologyCellT cellImmunityInterleukin 2CancerImmune systemGeneticsImmune Cell Function and InteractionCAR-T cell therapy researchImmunotherapy and Immune Responses